07 January 2025
Ananda Pharma plc
("Ananda" or the "Company")
Total Voting Rights
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Ananda announces that the Company has 4,299,146,581 ordinary shares of 0.2p each in issue ("Ordinary Shares"), each share carrying the right to one vote.
This figure of 4,299,146,581 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
| InvestorHub Engage with us directly at Ananda Pharma Investor Hub
| Sign up at https://investors.anandapharma.co.uk
|
| ANANDA PHARMA PLC Chief Executive Officer Melissa Sturgess
Jeremy Sturgess-Smith
| +44 (0)7463 686 497 ir@anandapharma.co.uk |
| SP ANGEL CORPORATE FINANCE LLP Corporate Finance Richard Morrison Caroline Rowe | +44 (0)20 3470 0470 |
| Corporate Broking Abigail Wayne Rob Rees
| |
| Yellow Jersey PR Charles Goodwin Zara McKinlay | +44 (0)20 3004 9512
|
About Ananda Pharma plc
Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions
For further information on the Company visit https://www.anandapharma.co.uk/ or sign up at https://investors.anandapharma.co.uk
https://investors.anandapharma.co.uk/link/Ky0jBr
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
